These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Alterations of glomerular and extracellular glutathione peroxidase levels in patients and rats with focal segmental glomerulosclerosis. Chen HC; Guh JY; Lai YH J Lab Clin Med; 2001 Apr; 137(4):279-83. PubMed ID: 11283522 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism. Patrignani P; Filabozzi P; Catella F; Pugliese F; Patrono C J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977 [TBL] [Abstract][Full Text] [Related]
15. Dietary protein and the progression of renal disease. Meyer TW; Lawrence WE; Brenner BM Kidney Int Suppl; 1983 Dec; 16():S243-7. PubMed ID: 6588259 [No Abstract] [Full Text] [Related]
16. The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome. Tarugi P; Nicolini S; Albertazzi L; Marchi L; Calandra S; Salvati P Aging (Milano); 1994 Oct; 6(5):381-90. PubMed ID: 7893785 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway. Tobias LD; Hamilton JG Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605 [No Abstract] [Full Text] [Related]
18. Inhibition of converting enzyme and thromboxane synthetase in a model of progressive renal disease; effects of enalapril and RS-86328 in the rat. Rosenkranz RP; Hayashi CM Proc West Pharmacol Soc; 1988; 31():81-5. PubMed ID: 2850566 [No Abstract] [Full Text] [Related]
19. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials. Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212 [TBL] [Abstract][Full Text] [Related]
20. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. Gresele P; Deckmyn H; Arnout J; Nenci GG; Vermylen J Thromb Haemost; 1989 Jun; 61(3):479-84. PubMed ID: 2552606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]